Benefit of revascularization for stable ischaemic heart disease: the jury is still out

MeSH terms

• Angiotensin-Converting Enzyme Inhibitors / therapeutic use
• Coronary Artery Bypass
• Fractional Flow Reserve, Myocardial / physiology
• Humans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
• Myocardial Ischemia / physiopathology
• Myocardial Ischemia / therapy*
• Myocardial Revascularization*
• Patient Selection
• Percutaneous Coronary Intervention
• Practice Guidelines as Topic
• Randomized Controlled Trials as Topic
• Risk Factors
• Treatment Outcome